El-Domyati M M, El-Fakahany H M, Morad K E
Department of Dermatology STD's & Andrology, Al-Minya University Hospital, Egypt.
Andrologia. 2009 Oct;41(5):319-21. doi: 10.1111/j.1439-0272.2009.00933.x.
Sildenafil citrate is a selective phosphodiesterase 5 (PDE-5) inhibitor and partial phosphodiesterase 6 inhibitor prescribed for erectile dysfunction. Post-marketing case reports of nonarteritic anterior ischaemic optic neuropathy (NAION) over the past few years suggest a potential link with PDE-5 inhibitors. We report a case of a 48-year-old male patient who had acute vision loss 36 h after the intake of 50 mg sildenafil citrate. NAION occurred at a period of minimal blood level of sildenafil citrate. So, erectile dysfunction drugs must be strongly considered with NAION even though their users may have neither predisposing nor precipitating factors for NAION and even if occurring at a time of minimal blood level of these drugs.
枸橼酸西地那非是一种选择性磷酸二酯酶5(PDE - 5)抑制剂和部分磷酸二酯酶6抑制剂,用于治疗勃起功能障碍。过去几年上市后关于非动脉性前部缺血性视神经病变(NAION)的病例报告提示其与PDE - 5抑制剂之间可能存在关联。我们报告一例48岁男性患者,在服用50毫克枸橼酸西地那非36小时后出现急性视力丧失。NAION发生在枸橼酸西地那非血药浓度最低的时期。因此,即使使用勃起功能障碍药物的患者可能既没有NAION的易感因素也没有促发因素,而且即使在这些药物血药浓度最低的时候发生NAION,也必须高度重视勃起功能障碍药物与NAION之间的关系。